The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development
Open accessAbstract
Glioblastoma cells secrete extra-cellular vesicles (EVs) containing microRNAs (miRNAs). Analysis of these EV miRNAs in the bio-fluids of afflicted patients represents a potential platform for biomarker development. However, the analytic algorithm for quantitative assessment of EV miRNA remains under-developed. Here, we demonstrate that the reference transcripts commonly used for quantitative PCR (including GAPDH, 18S rRNA, and hsa-miR-103) were unreliable for assessing EV miRNA. In this context, we quantitated EV miRNA in absolute terms and normalized this value to the input EV number. Using this method, we examined the abundance of miR-21, a highly over-expressed miRNA in glioblastomas, in EVs. In a panel of glioblastoma cell lines, the cellular levels of miR-21 correlated with EV miR-21 levels (p<0.05), suggesting that glioblastoma cells actively secrete EVs containing miR-21. Consistent with this hypothesis, the CSF EV miR-21 levels of glioblastoma patients (n=13) were, on average, ten-fold higher than levels in EVs isolated from the CSF of non-oncologic patients (n=13, p<0.001). Notably, none of the glioblastoma CSF harbored EV miR-21 level below 0.25 copies per EV in this cohort. Using this cut-off value, we were able to prospectively distinguish CSF derived from glioblastoma and non-oncologic patients in an independent cohort of twenty-nine patients (Sensitivity=87%; Specificity=93%; AUC=0.91, p<0.01). Our results suggest that CSF EV miRNA analysis of miR-21 may serve as a platform for glioblastoma biomarker development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gercel-Taylor, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,288
RetractedPregnancy-Associated Exosomes and Their Modulation of T Cell Signaling
Taylor, D. D., Akyol, S., & Gercel-Taylor, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1534 · Cited by 297
RetractedAnalysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine
Zweig, M. H., & Campbell, G. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.4.561 · Cited by 6,569
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
Self-citationBustin, S. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250169 · Cited by 3,872
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
B lymphocytes secrete antigen-presenting vesicles.
Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., & Geuze, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1161 · Cited by 3,546 · cited 1×
“Since non-neoplastic cells secrete EVs [18–20] and they outnumber neoplastic cells by several orders of magnitude in a patient [21], tumor-specific EVs remain a rarity in clinical samples [22].”
BackgroundArroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019055108 · Cited by 3,294
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., & Vescovi, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
Witwer, K. W., Buzás, E. I., Bemis, L. T., Bora, A., Lässer, C., Lötvall, J., Nolte‐‘t Hoen, E. N., Piper, M. G., Sivaraman, S., Skog, J., et al. (2013) · Journal of Extracellular Vesicles · doi:10.3402/jev.v2i0.20360 · Cited by 2,421
Self-citationLee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,311
Giard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H., & Parks, W. P. (1973) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1417 · Cited by 2,289
Filipe, V., Hawe, A., & Jiskoot, W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0073-2 · Cited by 1,885 · cited 1×
“EVs were isolated by ultracentrifugation and their numbers were determined by Nanoparticle Tracking Analysis [58–61].”
MethodReal-time RT-PCR normalisation; strategies and considerations
Huggett, J., Dheda, K., Bustin, S., & Zumla, A. (2005) · Genes & Immunity · doi:10.1038/sj.gene.6364190 · Cited by 1,856
Housekeeping genes as internal standards: use and limits
Thellin, O., Zorzi, W., Lakaye, B., De Borman, B., Coumans, B., Hennen, G., Grisar, T., Igout, A., & Heinen, E. (1999) · Journal of Biotechnology · doi:10.1016/s0168-1656(99)00163-7 · Cited by 1,544
Detection of microRNA Expression in Human Peripheral Blood Microvesicles
Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., Xiao, T., Schafer, J., Lee, M.-L. T., Schmittgen, T. D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003694 · Cited by 1,452
Akers, J. C., Gonda, D., Kim, R., Carter, B. S., & Chen, C. C. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1084-8 · Cited by 1,423 · cited 1×
“EVs isolated from biofluids can encompass exosomes, microvesicles, retrovirus-like particles (RLPs) and apoptotic bodies [66,67].”
BackgroundSelf-citationExciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
Van Meir, E. G., Hadjipanayis, C. G., Norden, A. D., Shu, H. K., Wen, P. Y., & Olson, J. J. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20069 · Cited by 1,372
Student (1908) · Biometrika · doi:10.1093/biomet/6.1.1 · Cited by 1,363
Exosomal-like vesicles are present in human blood plasma
Caby, M.-P., Lankar, D., Vincendeau-Scherrer, C., Raposo, G., & Bonnerot, C. (2005) · International Immunology · doi:10.1093/intimm/dxh267 · Cited by 1,343
Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
Rabinowits, G., Gerçel-Taylor, C., Day, J. M., Taylor, D. D., & Kloecker, G. H. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.006 · Cited by 1,262
Twenty-Five Years of Quantitative PCR for Gene Expression Analysis
VanGuilder, H. D., Vrana, K. E., & Freeman, W. M. (2008) · BioTechniques · doi:10.2144/000112776 · Cited by 1,246
Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences
Balaj, L., Lessard, R., Dai, L., Cho, Y.-J., Pomeroy, S. L., Breakefield, X. O., & Skog, J. (2011) · Nature Communications · doi:10.1038/ncomms1180 · Cited by 1,187
Self-citationAnalysis of mutation in human cells by using an Epstein-Barr virus shuttle system.
DuBridge, R. B., Tang, P., Hsia, H. C., Leong, P. M., Miller, J. H., & Calos, M. P. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.1.379 · Cited by 1,133
Exosomes: secreted vesicles and intercellular communications
Théry, C. (2011) · F1000 Biology Reports · doi:10.3410/b3-15 · Cited by 989
Control Selection for RNA Quantitation
Suzuki, T., Higgins, P. J., & Crawford, D. R. (2000) · BioTechniques · doi:10.2144/00292rv02 · Cited by 875
GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues
Barber, R. D., Harmer, D. W., Coleman, R. A., & Clark, B. J. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00025.2005 · Cited by 844
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy
Shao, H., Chung, J., Balaj, L., Charest, A., Bigner, D. D., Carter, B. S., Hochberg, F. H., Breakefield, X. O., Weissleder, R., & Lee, H. (2012) · Nature Medicine · doi:10.1038/nm.2994 · Cited by 759
Self-citationTrang, P., Wiggins, J. F., Daige, C. L., Cho, C., Omotola, M., Brown, D., Weidhaas, J. B., Bader, A. G., & Slack, F. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.48 · Cited by 667
TCR Activation of Human T Cells Induces the Production of Exosomes Bearing the TCR/CD3/ζ Complex
Blanchard, N., Lankar, D., Faure, F., Regnault, A., Dumont, C., Raposo, G., & Hivroz, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3235 · Cited by 660 · cited 1×
“Since non-neoplastic cells secrete EVs [18–20] and they outnumber neoplastic cells by several orders of magnitude in a patient [21], tumor-specific EVs remain a rarity in clinical samples [22].”
BackgroundIshii, N., Maier, D., Merlo, A., Tada, M., Sawamura, Y., Diserens, A., & Van Meir, E. G. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00536.x · Cited by 569
Francis Galton's Account of the Invention of Correlation
Stigler, S. M. (1989) · Statistical Science · doi:10.1214/ss/1177012580 · Cited by 528
D'Souza-Schorey, C., & Clancy, J. W. (2012) · Genes & Development · doi:10.1101/gad.192351.112 · Cited by 528
Exosome/microvesicle-mediated epigenetic reprogramming of cells.
Camussi, G., Deregibus, M. C., Bruno, S., Grange, C., Fonsato, V., & Tetta, C. (2011) · American Journal of Cancer Research · Cited by 505
Identification and proteomic profiling of exosomes in human cerebrospinal fluid
Street, J. M., Barran, P. E., Mackay, C. L., Weidt, S., Balmforth, C., Walsh, T. S., Chalmers, R. T., Webb, D. J., & Dear, J. W. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-5 · Cited by 490
Hong, B. S., Cho, J.-H., Kim, H., Choi, E.-J., Rho, S., Kim, J., Kim, J. H., Choi, D.-S., Kim, Y.-K., Hwang, D., et al. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-556 · Cited by 443
Intercellular Transport of MicroRNAs
Boon, R. A., & Vickers, K. C. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300139 · Cited by 387
Exosomal Tumor MicroRNA Modulates Premetastatic Organ Cells
Rana, S., Malinowska, K., & Zöller, M. (2013) · Neoplasia · doi:10.1593/neo.122010 · Cited by 346
Two established in vitro cell lines from human mesenchymal tumours
Ponten, J., & Saksela, E. (1967) · International Journal of Cancer · doi:10.1002/ijc.2910020505 · Cited by 345
U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line
Clark, M. J., Homer, N., O'Connor, B. D., Chen, Z., Eskin, A., Lee, H., Merriman, B., & Nelson, S. F. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000832 · Cited by 310
Teplyuk, N. M., Mollenhauer, B., Gabriely, G., Giese, A., Kim, E., Smolsky, M., Kim, R. Y., Saria, M. G., Pastorino, S., Kesari, S., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos074 · Cited by 302
Self-citationIdentifying mRNA, MicroRNA and Protein Profiles of Melanoma Exosomes
Xiao, D., Ohlendorf, J., Chen, Y., Taylor, D. D., Rai, S. N., Waigel, S., Zacharias, W., Hao, H., & McMasters, K. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046874 · Cited by 277
Møller, H. G., Rasmussen, A. P., Andersen, H. H., Johnsen, K. B., Henriksen, M., & Duroux, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8349-7 · Cited by 266
RNA Trafficking by Acute Myelogenous Leukemia Exosomes
Huan, J., Hornick, N. I., Shurtleff, M. J., Skinner, A. M., Goloviznina, N. A., Roberts, C. T., & Kurre, P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2184 · Cited by 259
Current management of glioblastoma multiforme
Grossman, S. A., & Batara, J. F. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.07.005 · Cited by 241
Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients
Gercel-Taylor, C., Atay, S., Tullis, R. H., Kesimer, M., & Taylor, D. D. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.06.004 · Cited by 232
Qi, L., Bart, J., Tan, L. P., Platteel, I., Sluis, T. V. D., Huitema, S., Harms, G., Fu, L., Hollema, H., & Berg, A. V. D. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-163 · Cited by 229
Argonaute 2 Complexes Selectively Protect the Circulating MicroRNAs in Cell-Secreted Microvesicles
Li, L., Zhu, D., Huang, L., Zhang, J., Bian, Z., Chen, X., Liu, Y., Zhang, C.-Y., & Zen, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046957 · Cited by 216
MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
Joshi, K., Banasavadi-Siddegowda, Y., Mo, X., Kim, S.-H., Mao, P., Kig, C., Nardini, D., Sobol, R. W., Chow, L. M. L., Kornblum, H. I., et al. (2013) · Stem Cells · doi:10.1002/stem.1358 · Cited by 214
Self-citationPlasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma
Wang, Q., Li, P., Li, A., Jiang, W., Wang, H., Wang, J., & Xie, K. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-97 · Cited by 202
CXCR4 expression mediates glioma cell invasiveness
Ehtesham, M., Winston, J. A., Kabos, P., & Thompson, R. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209302 · Cited by 198
Sorensen, A. G., Batchelor, T. T., Wen, P. Y., Zhang, W.-T., & Jain, R. K. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1204 · Cited by 192
Noerholm, M., Balaj, L., Limperg, T., Salehi, A., Zhu, L. D., Hochberg, F. H., Breakefield, X. O., Carter, B. S., & Skog, J. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-22 · Cited by 190 · cited 3×
“Enrichment of miRNA in EV content [9] renders EVs a particularly attractive platform.”
BackgroundSelf-citationWang, H., Wang, H., Shen, W., Huang, H. J., Hu, L., Ramdas, L., Zhou, Y., Liao, W. S. ‐., Fuller, G. N., & Zhang, W. (2003) · PubMed · Cited by 189
Vallhov, H., Gutzeit, C., Johansson, S. M., Nagy, N., Paul, M., Li, Q., Friend, S. L., George, T. C., Klein, E., Scheynius, A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001145 · Cited by 144
miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling
Bhagat, T. D., Zhou, L., Sokol, L., Kessel, R. M., Cáceres, G., Gundabolu, K., Tamari, R., Gordon, S. A. K., Mantzaris, I., Jodlowski, T., et al. (2013) · Blood · doi:10.1182/blood-2011-12-397067 · Cited by 143
Jarboe, J. S., Johnson, K. R., Choi, Y., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1493 · Cited by 139
Gu, C., Banasavadi‐Siddegowda, Y., Joshi, K., Nakamura, Y., Kurt, H., Gupta, S., & Nakano, I. (2013) · Stem Cells · doi:10.1002/stem.1322 · Cited by 119
Self-citationDeftereos, G., Corrie, S. R., Feng, Q., Morihara, J. K., Stern, J., Hawes, S. E., & Kiviat, N. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028423 · Cited by 105
Wotschofsky, Z., Meyer, H.-A., Jung, M., Fendler, A., Wagner, I., Stephan, C., Busch, J. F., Erbersdobler, A., Disch, A. C., Mollenkopf, H., et al. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.06.009 · Cited by 96
Bangert, A., Cristofanon, S., Eckhardt, I., Abhari, B. A., Kolodziej, S., Häcker, S., Vellanki, S. H., Lausen, J., Debatin, K., & Fulda, S. (2012) · Oncogene · doi:10.1038/onc.2011.614 · Cited by 87
Wright, M. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-953-2_41 · Cited by 79
Guduric‐Fuchs, J., O’Connor, A., Cullen, A., Harwood, L., Medina, R. J., O’Neill, C. L., Stitt, A. W., Curtis, T. M., & Simpson, D. A. C. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24084 · Cited by 74
Thang, N. N. T., Derouazi, M., Philippin, G., Arcidiaco, S., Berardino-Besson, W. D., Masson, F., Hoepner, S., Riccadonna, C., Burkhardt, K., Guha, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3074 · Cited by 70
Microglial action in glioma: A boon turns bane
Ghosh, A., & Chaudhuri, S. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.03.003 · Cited by 46
Gonda, D. D., Akers, J. C., Kim, R., Kalkanis, S. N., Hochberg, F. H., Chen, C. C., & Carter, B. S. (2012) · Neurosurgery · doi:10.1227/neu.0b013e3182846e63 · Cited by 44
Self-citationde Biase, D., Visani, M., Morandi, L., Marucci, G., Taccioli, C., Cerasoli, S., Baruzzi, A., Pession, A., & the PERNO Study group (2012) · PLoS ONE · doi:10.1371/journal.pone.0035596 · Cited by 40
Visani, M., de Biase, D., Marucci, G., Taccioli, C., Baruzzi, A., Pession, A., & the PERNO Study group (2013) · PLoS ONE · doi:10.1371/journal.pone.0055314 · Cited by 35
Probes for Intracellular RNA Imaging in Live Cells
Santangelo, P. J., Alonas, E. J., Jung, J., Lifland, A. W., & Zurla, C. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-388448-0.00028-0 · Cited by 29
A multi-gene transcriptional profiling approach to the discovery of cell signature markers
Wada, Y., Li, D., Merley, A., Zukauskas, A., Aird, W. C., Dvorak, H. F., & Shih, S. (2010) · Cytotechnology · doi:10.1007/s10616-010-9315-8 · Cited by 23
A small interference RNA screen revealed proteasome inhibition as strategy for glioblastoma therapy.
Ng, K., Nitta, M., Hu, L., Kesari, S., Kung, A. L., D’Andrea, A. D., & Chen, C. C. (2009) · PubMed · Cited by 9
Self-citation
Cited by
Doyle, L., & Wang, M. (2019) · Cells · doi:10.3390/cells8070727 · Cited by 3,236
Exosomes in cancer development, metastasis, and immunity
Zhang, L., & Yu, D. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.04.004 · Cited by 870
Exosome mediated communication within the tumor microenvironment
Milane, L., Singh, A., Mattheolabakis, G., Suresh, M., & Amiji, M. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.029 · Cited by 742
MicroRNAome genome: A treasure for cancer diagnosis and therapy
Berindan‐Neagoe, I., Monroig, P. D. C., Pasculli, B., & Calin, G. A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21244 · Cited by 522
Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
Singh, N., Miner, A., Hennis, L., & Mittal, S. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.79 · Cited by 398
Metadata
- Authors
- Akers, J. C., Ramakrishnan, V., Kim, R., Skog, J., Nakano, I., Pingle, S., Kalinina, J., Hua, W., Kesari, S., Mao, Y., Breakefield, X. O., Hochberg, F. H., Van Meir, E. G., Carter, B. S., & Chen, C. C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-10-21
- Volume
- 8
- Issue
- 10
- Pages
- e78115
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2150309717
- Cited by
- 337
- References
- 76
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.